Ticker Details
ALX Oncology Holdings Inc.
IPO Date:	July 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$207.23M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 4.48%
Avg Daily Range (30 D):	$0.06 | 3.51%
Avg Daily Range (90 D):	$0.09 | 4.68%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.96M
Avg Daily Volume (90 D):	.9M

Trade Size
Avg Trade Size (Sh.):	116
Avg Trade Size (Sh.) (30 D):	160
Avg Trade Size (Sh.) (90 D):	163

Institutional Trades
Total Institutional Trades:	845
Avg Institutional Trade:	$1.82M
Avg Institutional Trade (30 D):	$1.76M
Avg Institutional Trade (90 D):	$1.46M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.95M
Avg Closing Trade (30 D):	$.51M
Avg Closing Trade (90 D):	$1.05M
Avg Closing Volume:	90.3K

News

Feb 27, 2026 @ 1:00 PM ALX Oncology Reports Fourth Quarter and Full Year ... Source: Alx Oncology Holdings Inc.

Jan 8, 2026 @ 4:00 PM ALX Oncology to Present at the 44th Annual J.P. Mo... Source: Alx Oncology Holdings Inc.

Dec 7, 2025 @ 1:00 PM ALX Oncology Announces Positive Results from Ongoi... Source: Alx Oncology Holdings Inc.

Nov 27, 2025 @ 6:00 PM HER2-positive Gastric Cancer Clinical Trial Pipeli... Source: Delveinsight

Nov 18, 2025 @ 4:00 PM ALX Oncology to Present at Upcoming Investor Confe... Source: Alx Oncology Holdings Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.49	$-.17	$-.42
Diluted EPS	$-1.49	$-.17	$-.42
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-88.87M	$-17.93M	$-22.85M
Operating Income / Loss	$-91.17M	$-18.97M	$-23.02M
Cost of Revenue
Net Cash Flow	$11.67M	$15.91M	$-7.07M
PE Ratio